Purdue Pharma is becoming increasingly reluctant to develop new opioids, and is diversifying following FDA approval of a drug used to treat constipation associated with the painkillers.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho